Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

rTMS-behandling av spasticitet hos barn med cerebral pares - en RCT

23 september 2026 uppdaterad av: Winnie Wan Yee Tso (Dr), The University of Hong Kong

Repetitiv transkraniell magnetisk stimulering (rTMS) för behandling av spasticitet hos barn med hemiplegisk cerebral pares - en randomiserad kontrollerad studie

This RCT aims to investigate the effect of repetitive transcranial magnatic stimulation (rTMS) in treating children with hemiplegoc cerebral palsy. The study will measure any improvement in spasticity after using contra-lesional inhibitory rTMS follow by intensive limb training.

Participants will attend a 10-day rTMS treatment sessions, follow by intensive training of the impaired limb. They will also undergo MRI scans before and after the treatment to investiagte the underlying neurophysiological mechanisms that lead to changes clinically by using TMS as well as MR-DKI. Researchers will compare the intervention group and the sham group to see if rTMS could result in improvement of participants' spasticity.

Studieöversikt

Detaljerad beskrivning

Cerebral palsy is the most common cause of lifelong physical disability in childhood, with an estimated prevalence of 1.5 per 1000 living biths for primary school-aged children. Spasticity is the most common symptoms in children with cerebral palsy, leading to muscle weakness affecting gross motor functions and causing complications such as pain, contracture and subluzation which will lead to inability to perform activity-based training and subsequently lead to further muscle weakness. Standard therapy with regular physiotherapy and occupational therapy are essential but time-consuming and the effects might not last for longer duration. Patients or caregivers decline medications because of side effects drowsiness while other interventions such as intra-thecal baclofen pump, rhizotomy or surgery are invasive.

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has the ability to modulate excitation of the motor cortex area of the brain. There were past studies suggesting that using contralesional inhibitory rTMS was safe and feasible for patients with paediatric subcortical stroke and seemed to improve hand function in patients with hemiparesis. However, limited studies have been published on the effects of rTMS on improving spasticity in children with cerebral palsy. Hence, the objective of this study is to use low-frequency rTMS to the contra-lesional hemisphere in children with hemiplegic cerebral palsy to investigate if rTMS follow by intensive limb training would improve spasiticity of these children and whether the improvement can be sustained for a longer time. The underlying mechanisms that lead to the changes clinically will also be investigated by TMS and MRI.

Studietyp

Interventionell

Inskrivning (Beräknad)

20

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Winnie Wan Yee Tso, MBBS
  • Telefonnummer: +85222554295
  • E-post: wytso@hku.hk

Studera Kontakt Backup

Studieorter

    • Hong Kong
      • Hong Kong, Hong Kong, Hong Kong, 0000
        • Rekrytering
        • Li Ka Shing Faculty of Medicine
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

4 år till 18 år (Barn, Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Patients aged between 4 years and 18 years
  • Diagnosis of hemiplegia
  • Upper limb spasticity ≥ 1
  • IQ ≥ 50

Exclusion Criteria:

  • Any contra-indications to rTMS
  • Severe spasticity (score of 4 or more in Ashworth scale)
  • Uncontrollable epilepsy
  • History of Botulinum toxin A injection in previous 6 months
  • Upper limb casting in previous 6 months

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Interventional rTMS group

The intervention group will receive 1 Hz active rTMS during treatment, lasting for 20 minutes, follow up by 1.5 hours of motor training.

1 Hz rTMS treatment for 20 mins, followed by 1.5 hours of motor training.

Sham Comparator: Sham rTMS group

The sham group will not receive any Hz of rTMS during treatment, also lasting for 20 minutes with 1.5 hours of motor training.

Sham Hz rTMS treatment for 20 mins, followed by 1.5 hours of motor training.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Modified Ashworth Scale
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

Clinical measure of spasticity. Scores range from 0 to 4, with a higher score indicate worse in muscle tone

Baseline, Day 10, 17 of intervention and 2 months post intervention
The range of motion scores
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

ROM of thumb adduction, wrist dorsal flexion and extension, and elbow dorsal flexion and extension. Patients' range of motion score will be compared to the normative values

Baseline, Day 10, 17 of intervention and 2 months post intervention
The Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2)
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

The BOT-2 provides a comprehensive overview of fine and gross motor skills in children and young adults within school age-range.

Baseline, Day 10, 17 of intervention and 2 months post intervention

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Gross motor function measure
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

Changes in motor function. A 4-point Likert scale with higher score indicates better motor function

Baseline, Day 10, 17 of intervention and 2 months post intervention
Pediatric Quality of Life Cerebral Palsy module
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

Quality of life measurement. Scores range from 0 to 100 with higher score indicate better quality of life.

Baseline, Day 10, 17 of intervention and 2 months post intervention
MRI Brain: fMRI and DKI
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

Functional MRI and Diffusion Kurtosis Imaging measuring the brain microstructural changes and structural connectivity during the intervention

Baseline, Day 10, 17 of intervention and 2 months post intervention
Purdue Pegboard Test
Tidsram: Baseline, Day 10, 17 of intervention and 2 months post intervention

A standardized evaluation tool used to measure gross movements of hands, fingers, and arms, as well as fine fingertip dexterity.

Baseline, Day 10, 17 of intervention and 2 months post intervention

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

13 januari 2024

Primärt slutförande (Beräknad)

1 december 2029

Avslutad studie (Beräknad)

1 december 2029

Studieregistreringsdatum

Först inskickad

7 november 2023

Först inskickad som uppfyllde QC-kriterierna

10 november 2023

Första postat (Faktisk)

13 november 2023

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

28 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

23 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera